793 abstracts found.



Results filter

Genomics and histopathology of tumours, a translational challenge

Year:

Session type:

Theme:

Leon P Bignold1

1University of Adelaide, Adelaide, SA, Australia


Three dimensional culture sensitizes Multiple Myeloma cells to Histone methyltransferases (HMTases) inhibitor

Year:

Session type:

Theme:

Amal Arhoma1,Andy Chantry2,Neil Cross1

1Sheffield Hallam University, Sheffield, UK,2The Medical School, Sheffield University, Sheffield, UK


Childbearing patterns and ovarian cancer in the Million Women Study: variation by histological subtype

Year:

Session type: ,

Theme:

Kezia Gaitskell1,Jane Green1,Kirstin Pirie1,Gillian Reeves1,Valerie Beral1,on behalf of the Million Women Study Collaborators1

1Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK


Phase II clinical trial of 6 mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours

Year:

Session type:

Theme:

Corran Roberts1,Lucy Boyle2,Victoria Strauss1,Sylwia Kopijasz2,Charlie Gourley3,Marcia Hall4,Ana Montes5,Jacinta Abraham6,Andrew Clamp7,Richard Kennedy8,Susana Banerjee9,Shibani Nicum10

1Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK,2Oncology Clinical Trials Office, University of Oxford, Oxford, UK,3University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, UK,4Mount Vernon Cancer Centre, Northwood, Middlesex, UK,5Guy’s and St. Thomas’ NHS Trust, London, UK,6Velindre Cancer Centre, Cardiff, UK,7The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK,8Centre for Cancer Research and Cell Biology, Queen’s University of Belfast, Belfast, UK,9The Royal Marsden NHS Foundation Trust, London, UK,10Oxford University Hospitals NHS Trust, Oxford, UK


Investigating the role of PKC epsilon in the response to DNA catenation at the metaphase-to-anaphase boundary.

Year:

Session type:

Theme:

Joanna Kelly1,Tanya Pike1,Nicola Brownlow1,3,Peter Parker1,2

1The Francis Crick Institute, London, UK,2King’s College London, London, UK,3Center for Genomic Regulation, Barcelona, Spain


Oropharyngeal cancers attributable to HPV in the United Kingdom: a cross-sectional observational multi-centre study

Year:

Session type:

Theme:

Andrew Schache1,2,Ned Powell3,Max Robinson6,Kate Cushieri4,Mererid Evans5,Terry Jones1,2

1University of Liverpool, Liverpool, UK,2Aintree University Hospital, Liverpool, UK,3Cardiff University, Cardiff, UK,4Scottish Human Papillomavirus Reference Laboratory, Edinburgh, UK,5Velindre NHS Trust, Cardiff, UK,6Newcastle University, Newcastle, UK


Clinical response, PFS and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) versus IPI monotherapy in CheckMate 069 study

Year:

Session type: ,

Theme:

Stephen Hodi1,Michael Postow2,Jason Chesney3,Anna Pavlick4,Caroline Robert5,Kenneth Grossmann6,David McDermott7,Gerald Linette8,Nicolas Meyer9,Jeffrey Giguere10,Sanjiv Agarwala11,Montaser Shaheen12,Marc Ernstoff13,David Minor14,April Salama15,Matthew Taylor16,Patrick Ott1,Christine Horak17,Paul Gagnier18,Jedd Wolchok2

1Dana-Farber Cancer Institute, Boston, MA, USA,2Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA,3J. Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA,4New York University, Perlmutter Cancer Center, New York, NY, USA,5Gustave, Roussy and Paris-Sud University, Villejuif-Paris-Sud, France,6Huntsman Cancer Institute, Salt Lake City, UT, USA,7Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA,8Washington University, St. Louis, MO, USA,9Institut Universitaire du Cancer, Toulouse, France,10Greenville Health System, Greenville, SC, USA,11St. Luke’s Cancer Center, Bethlehem, PA, USA,12University of New Mexico, Albuquerque, NM, USA,13Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA,14California Pacific Melanoma Center, San Francisco, CA, USA,15Duke University, Durham, NC, USA,16Oregon Health & Science University, Portland, OR, USA,17Bristol-Myers Squibb, Princeton, NJ, USA,18Bristol-Myers Squibb, Wallingford, CT, USA


Role of Galectin-3 in Breast carcinoma chemoresistance

Year:

Session type:

Theme:

SUHAIL AL- SALAM1,MOHAMED FAHIM2,MOHAMMED JALOUDI3

1COLLEGE OF MEDICINE-UAE UNIVERSITY, ALAIN, United Arab Emirates,2DEPARTMENT OF SURGERY-TAWAM HOSPITAL, ALAIN, United Arab Emirates,3DEPARTMENT OF ONCOLOGY-TAWAM, ALAIN, United Arab Emirates


Young patients with HER2+ breast cancer rarely have a germline mutation in a known cancer predisposition gene

Year:

Session type: , ,

Theme:

Diana Eccles1,Li Na2,Tom Maishman1,Ellen Copson1,Ian Campbell2

1University of Southampton, Southampton, UK,2Peter Macallum Cancer Centre, Melbourne, Australia


CheckMate 067: a phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy treatment-naïve patients (pts) with advanced melanoma (MEL)

Year:

Session type:

Theme:

Jedd Wolchok1,Vanna Chiarion-Sileni2,Rene Gonzalez3,Piotr Rutkowski4,Jean Grob5,Charles Cowey6,Christopher Lao7,Dirk Schadendorf8,Pier Ferrucci9,Michael Smylie10,Reinhard Dummer11,Andrew Hill12,John Haanen13,Michele Maio14,Grant McArthur15,Arvin Yang16,Linda Rollin17,Christine Horak16,James Larkin18,Stephen Hodi19

1Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA,2Oncology Institute of Veneto IRCCS, Padua, Italy,3University of Colorado Cancer Center, Denver, CO, USA,4Maria Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland,5Hospital de la Timone, Marseille, France,6Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA,7University of Michigan, Ann Arbor, MI, USA,8Department of Dermatology, University of Essen, Essen, Germany,9European Institute of Oncology, Milan, Italy,10Cross Cancer Institute, Edmonton, AB, Canada,11Universitäts Spital, Zurich, Switzerland,12Tasman Oncology Research, Queensland, Australia,13Netherlands Cancer Institute, Amsterdam, The Netherlands,14Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy,15Peter MacCallum Cancer Centre, Victoria, Australia,16Bristol-Myers Squibb, Princeton, NJ, USA,17Bristol-Myers Squibb, Wallingford, CT, USA,18Royal Marsden Hospital, London, UK,19Dana-Farber Cancer Institute, Boston, MA, USA


Re-challenge with weekly paclitaxel in patients with advanced epithelial ovarian cancer, fallopian tube and primary peritoneal cancer (PPC). 

Year:

Session type:

Theme:

Alicia Okines1,Shankar Bodla1,Martin Gore1,Stan Kaye1,Susana Banerjee1

1The Royal Marsden NHS Foundation Trust, London & Surrey, UK


Use of continuous prophylactic dalteparin to reduce arterial and venous thromboembolism in patients undergoing neo-adjuvant and adjuvant cisplatin based chemotherapy for oesophago-gastric cancer

Year:

Session type:

Theme:

Martin Doak1,Lucy Wall1

1Edinburgh Cancer Centre, Scotland, UK


Exploring the role of BCL11A in the EMT program and metastasis

Year:

Session type:

Theme:

Dorothy Yang1,Fazal Hadi1,Walid Khaled1

1Department of Pharmacology, University of Cambridge, Cambridge, UK


Lysine specific demethylase 1 inhibition attenuates enzalutamide resistant androgen receptor V7 splice variant activation

Year:

Session type:

Theme:

Sergio Regufe da Mota1,Sarah Bailey1,Rosemary Strivens1,Annette Hayden1,Graham Packham1,Simon Crabb1

1Cancer Research UK Centre, University of Southampton, Southampton, UK


Importance of the insulin-like growth factor (IGF) signal transduction pathway and the type I IGF receptor in gastric cancer cells without HER2, FGFR2 or MET amplification

Year:

Session type:

Theme:

Marina Saisana1,S. Michael Griffin1,3,Felicity E.B. May1,2

1Northern Institute for Cancer Research, Newcastle upon Tyne, UK,2Newcastle University Institute for Ageing, Department of Pathology, Newcastle upon Tyne, UK,3Northern Oesophago-gastric Cancer Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK


Patients’ views on the role of music in the radiotherapy department.

Year:

Session type:

Theme: ,

Alison Stillie1,Catriona Baker2,Michael Blayney2,Matilda Coke2,Morven Davies2,Christina Fairley2,Katie Feather2,Rebecca Finch2

1Edinburgh Cancer Centre, Edinburgh, UK,2University of Edinburgh Medical School, Edinburgh, UK


Supporting carers of people affected by cancer and other long-term conditions at end of life

Year:

Session type:

Theme:

David Nelson1,Ros Kane1,Anna Thomson1,Ian McGonagle1

1University of Lincoln, Lincoln, Lincolnshire, UK


Salinomycin targets EZH2 driven epigenetic repression of death receptors in colon cancer stem cells

Year:

Session type:

Theme:

Anup Kumar Singh1,Shrankhla Maheshwari1,Rakesh K. Arya1,Dipak Datta1

1CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India


Management of brain metastases in patients with advanced HER2 positive and negative breast cancer and their outcomes

Year:

Session type:

Theme:

Jacqueline Grove1,Jenna Schafers1,Alison Stillie1

1Western General Hospital, Edinburgh, UK


Evaluation of  Hyponatraemia in Lung cancer patients: a U.K. teaching hospital  experience

Year:

Session type:

Theme:

ANKIT JAIN1,MARIAM JAFRI1,SALMA ALAM1,SOPHIE MASCALL1,RHIAN THOMAS1,JAMES KENDRICK1,JOYCE THOMPSON1

1Birmingham Heartlands Hospital, Birmingham, UK


Phase 1/2 study of nivolumab (NIVO) with or without ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC): CA209-032

Year:

Session type:

Theme:

Emiliano Calvo1,Scott J. Antonia2,Johanna Bendell3,Matthew Taylor4,Dirk Jäger5,Filippo de Braud6,Patrick A. Ott7,M. Catherine Pietanza8,Leora Horn9,Dung T. Le10,Michael A. Morse11,José A. López-Martin12,Paolo A. Ascierto13,Olaf Christensen14,Joseph F. Grosso14,Jason Simon14,Chen-Sheng Lin14,Joseph Paul Eder15

1START Madrid, Madrid, Spain,2H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,3Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA,4Oregon Health & Science University, Portland, OR, USA,5Heidelberg University Hospital, Heidelberg, Germany,6Istituto Nazionale dei Tumori, Milan, Italy,7Dana-Farber Cancer Institute, Boston, MA, USA,8Memorial Sloan Kettering Cancer Center, New York, NY, USA,9Vanderbilt-Ingram Cancer Center, Nashville, TN, USA,10The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA,11Duke University Medical Center, Durham, NC, USA,12Hospital Universitario 12 de Octubre, Madrid, Spain,13Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy,14Bristol-Myers Squibb, Princeton, NJ, USA,15Yale Comprehensive Cancer Center, New Haven, CT, USA


Effect of nivolumab (NIVO) on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): results of a phase III study (CheckMate 066)

Year:

Session type:

Theme:

Georgina Long1,Victoria Atkinson2,Paolo Ascierto3,Caroline Robert4,Jessica Hassel5,Piotr Rutkowski6,Kerry Savage7,Fiona Taylor8,Cheryl Coon8,Isabelle Gilloteau9,Homa Dastani9,Ian Waxman9,Amy Abernethy10

1Melanoma Institute Australia, North Sydney, NSW, Australia,2Gallipoli Medical Research Foundation and Princess Alexandra Hospital, Queensland, Australia,3Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy,4Institut Gustave-Roussy, Paris, France,5University Hospital Heidelberg, Dep. of Dermatology and National Center for Tumor Diseases, Heidelberg, Germany,6Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland,7BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada,8Adelphi Values, Boston, MA, USA,9Bristol-Myers Squibb, Princeton, NJ, USA,10Duke Cancer Institute, Durham, NC, USA


Correlation between MRI detected extra-mural vascular invasion in rectal cancer and metastatic disease: a meta-analysis

Year:

Session type:

Theme:

Muhammed Siddiqui1,2,Maneesh Chand2,jemma Bhoday1,2,Paris Tekkis3,Al-Mutaz Abulafi1,Gina Brown0

1Croydon University Hospital, Croydon, UK,2Royal Marsden Hospital, Surrey, UK,3Royal Marsden Hospital, Chelsea, UK


Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease

Year:

Session type:

Theme:

Jonine Figueroa1,2,Ruth Pfeiffer1,Louise Brinton1,Maya Palakal1,Amy Degnim3,Derek Radisky3,Lynn Hartmann3,Marlene Frost3,Melody Stallings3,Daphne Papathomas1,Stephen Hewitt1,Daniel Visscher3,Mark Sherman1

1National Cancer Institute, Bethesda, MD, USA,2University of Edinburgh, Edinburgh, Scotland, UK,3Mayo Clinic Cancer Center, Rochester, MN, USA


DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis

Year:

Session type:

Theme:

Chin Wen Png1,Madhushanee Weerasooriya1,Jing Guo2,Sharmy Jeniffer James1,Han Ming Poh1,Motomi Osato2,Richard Flavell3,Chen Dong4,Henry Yang2,Yongliang Zhang1

1Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Singapore,2Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore, Singapore,3Department of Immunology, Howard Hughes Medical Institute, Yale University, New Haven, Connecticut, USA,4Tsinghua University, Beijing, China


Keeping The Customer Satisfied #4 – We Need To Talk!  Responses From Patients To Questions On Research In The National Cancer Patient Experience Survey 2014

Year:

Session type:

Theme:

Richard Stephens1,Carolyn Morris1,Matthew Baker1,Robert West2,Sheila Fisher3,Sue Pavitt2,Jane Hanson4,Karen Inns3

1NCRI Consumer Forum, London, UK,2Leeds Institute of Health Science, Leeds, UK,3NIHR CRN:Cancer, Leeds, UK,4NIHR CRN:Kent Surrey Sussex, Brighton, UK


Chemoradiotherapy for locally advanced pancreas adenocarcinoma at Weston Park Hospital and comparison with the SCALOP clinical trial

Year:

Session type:

Theme:

Finbar Slevin1,Jonathan Wadsley1

1Weston Park Hospital, Sheffield, UK


Use of the PigA gene mutation assay as a novel blood-based biomarker for cancer progression in the Barrett’s oesophagus – oesophageal adenocarcinoma model

Year:

Session type:

Theme:

Hasan Haboubi1,2,Lisa Williams2,1,James Manson2,1,Owen Bodger1,Cathy Thornton1,Gareth Jenkins1

1Swansea University, Swansea, UK,2ABMU Health Board, Swansea, UK


The role of lipocalin 2 regulated by thyroid hormone in liver cancer

Year:

Session type:

Theme:

I-Hsiao Chung1,Kwang-Huei Lin1

1Chang-Gung University, Taoyuan, Taiwan


A model for care: 6 year experience of recruitment into breast cancer trials- a single centre perspective

Year:

Session type:

Theme:

Sheena Khanduri1,Helen Moore1

1Shrewsbury and Telford NHS Trust, Shrewsbury, Shropshire, UK


Target coverage during image-guided radiotherapy for prostate cancer – how relevant is the initial rectal volume?

Year:

Session type:

Theme:

Hemal Ariyaratne1,Hayley Chesham2,Roberto Alonzi1,3

1Mount Vernon Cancer Centre, Rickmansworth, UK,2Genesis Cancer Care, Queensland, Australia,3Cancer Partners UK, Elstree, UK


A novel way of pre assessment for patients undergoing chemotherapy can increase capacity and improve waiting times for cancer patients

Year:

Session type:

Theme:

Sheena Khanduri1,Wendy Davies1

1Shrewsbury and Telford NHS Trust, Shrewsbury,Shropshire, UK


Doctors’ views on audio recording of oncology consultations by patients

Year:

Session type:

Theme:

Hemal Ariyaratne1,David Woolf1

1Mount Vernon Cancer Centre, Northwood, UK


Statins as novel therapeutic agents in targeting TAMs within human NSCLC microenvironment

Year:

Session type:

Theme: ,

Esraa Aldujaily1,Tamihiro Kamata2,David Moore 3, John LeQuesne1,3,Catrin Pritchard1,2

1Cancer Studies, University of Leicester, UK,2Biochemistry Department, University of Leicester, UK,3Toxicology Unit, University of Leicester, UK


PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT)

Year:

Session type:

Theme:

Hisham Mehanna1,Wai Lup Wong2,Christopher A McConkey3,Joy K Rahman3,Max Robinson4,Andrew Hartley5,Christopher Nutting6,Ned Powell7,Hoda Al-Booz8,Martin Robinson9,Elizabeth Junor10,Claire Hulme11,Alison F Smith11,Peter Hall12,Bal Sanghera2,Janet A Dunn3

1InHANSE, University of Birmingham, Birmingham, UK,2Paul Strickland Scanner Centre, Mount Vernon Hospital, Middlesex, UK,3Warwick University Clinical Trials Unit, Coventry, UK,4Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle, UK,5Queen Elizabeth Hospital Birmingham, Birmingham, UK,6Royal Marsden Hospital, London, UK,7HPV Oncology Group, Institute of Cancer Genetics, Cardiff University, Cardiff, UK,8Bristol Haematology and Oncology Centre, Bristol, UK,9Weston Park Hospital, Sheffield, UK,10Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK,11University of Leeds, Leeds, UK,12St James University Hospital, Leeds, UK


Longitudinal single cell clonal analysis reveals evolutionary stasis and predetermined malignant potential in non-dysplastic Barrett’s Oesophagus

Year:

Session type: , ,

Theme:

Pierre Martinez1,Margriet R. Timmer2,Chiu T. Lau2,Sybren L. Meijer2,Fiebo J.W. ten Kate2,Rosalie C. Mallant-Hent3,9,Anton H.J. Naber4,9,Arnoud H.A.M. van Oijen5,9,Lubbertus C. Baak6,9,Pieter Scholten7,9,Clarisse J.M. Böhmer8,9,Paul Fockens2,Jacques J.G.H.M. Bergman2,9,Carlo C. Maley10,11,Trevor A. Graham1,Kausilia K. Krishnadath2,9

1Barts Cancer Institute – Queen Mary University of London, London, UK,2Academic Medical Center – University of Amsterdam, Amsterdam, The Netherlands,3Department of Gastroenterology and Hepatology, Flevoziekenhuis, Almere, The Netherlands,4Department of Gastroenterology and Hepatology, Tergooiziekenhuizen, Hilversum, The Netherlands,5Department of Gastroenterology and Hepatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands,6Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands,7Department of Gastroenterology and Hepatology, Sint Lucas Andreas Ziekenhuis, Amsterdam, The Netherlands,8Department of Gastroenterology and Hepatology, Spaarne Ziekenhuis, Hoofddorp, The Netherlands,9Gastroenterological Association, Amsterdam, The Netherlands,10Center for Evolution and Cancer, University of California at San Francisco, San Francisco, CA, USA,11Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, USA


FOLFIRINOX for the treatment of advanced pancreatic cancer: UK West Midlands experience

Year:

Session type:

Theme:

Ankit Jain1,Martin Scott Brown2,3,Peter Correa2,4,Sharmila Sothi2,Amy Davies1,Caroline Connolly5,Charles Candish6,David Peake1,Medy Tsalic7,Pankaj Punia1,Yuk Ting Ma1

1University Hospital Birmingham, Birmingham, West Midlands, UK,2University Hospital Coventry and Warwickshire, Coventry, West Midlands, UK,3George Eliot Hospital NHS Trust, Nuneaton, UK,4South Warwickshire NHS Foundation Trust, Warwickshire, UK,5University Hospitals of North Midlands NHS Trust, Stafford, UK,6Worcestershire Royal Hospital, Worcester, UK,7Heart of England NHS Foundation Trust, Birmingham, West Midlands, UK


Neo-adjuvant sunitinib to facilitate nephron sparing surgery in patients with renal cell carcinoma (RCC) in a solitary kidney.

Year:

Session type:

Theme:

Ankit Jain1,Shobhit Baijal2,Emilio Porfiri1

1University Hospital Birmingham, Birmingham, UK,2Heart of England NHS Trust, Birmingham, UK


Endo chemotherapy in cancer bladder no muscle invasive

Year:

Session type:

Theme:

Messaoud AYAD1,2,Neoual AKSIL1

1Centre anti cancer, Blida, Algeria,2University 1 medical college, Blida, Algeria


How is good and poor response to neoadjuvant therapy defined using histological and MRI regression scales in rectal cancer studies with reference to outcomes.

Year:

Session type:

Theme:

Muhammed Siddiqui1,2,Jemma Bhoday1,2,Nicholas Battersby1,Al-Mutaz Abulafi2,Paris Tekkis3,Gina Brown0

1Royal Marsden Hospital, Surrey, UK,2Croydon university Hospital, Surrey, UK,3Royal Marsden Hospital, London, UK


Targeting the glycolytic and inflammatory phenotype in breast cancer

Year:

Session type:

Theme:

Katherine Finegan1,Ayse Latif1,Brian Telfer1,Muhammad Babur1,Ian Stratford1,James O’Connor1,Kaye Williams1

1University of Manchester, Manchester, UK


Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study

Year:

Session type:

Theme:

Caroline Fairhurst1,Ian Watt1,2,Fabiola Martin1,2,Martin Bland1,William Brackenbury1

1University of York, York, UK,2Hull York Medical School, York, UK


A PROMS enabled, bespoke, web-based clinical database system for multicentre rectal Carcinoma registry

Year:

Session type:

Theme:

Mark Halling-Brown1,Adrian Franklin1,Alexandra Stewart1

1St. Luke’s Cancer Centre, Royal Surrey County Hospital, Guildford, Surrey, UK


Relapse after radical radiation based treatment for oropharyngeal cancer

Year:

Session type:

Theme:

Aravindhan Sundaramurthy1,Kirsty MacLennan1,Ioanna Fragkandrea-Nixon1

1Edinburgh Cancer Centre, Edinburgh, UK


Automated quantitative imaging feature extraction from the Oncology Medical Image Database

Year:

Session type:

Theme:

Mishal Patel1,Mark Halling-Brown1

1Royal Surrey County Hospital, Guildford, UK


Perceived risk and oral HPV infection in high risk adults: analysis of GUM clinic attendees in the UK

Year:

Session type:

Theme:

Rachael Dodd1,Jo Waller1,Laura Marlow1,Karly Louie2

1University College London, London, UK,2Cancer for Centre Prevention, Wolfson Institute of Preventative Medicine, London, UK


Why are girls unvaccinated or under vaccinated against human papillomavirus? A content analysis

Year:

Session type:

Theme:

Alice Forster1,Jo Waller1,Harriet Bowyer1,Laura Marlow1

1UCL, London, UK


The Process of Dying; biological changes towards the end of life

Year:

Session type:

Theme:

Seamus Coyle1,Aileen Scott1,Amara Nwosu1,Richard Latten1,James Wilson2,Stephen Mason1,Chris Probert2,John Ellershaw1

1Marie Curie Palliative Care Institute, Liverpool, UK,2Institute of Translational Medicine, Liverpool, UK


GTP cyclohydrolase as a novel mechanism for tumour growth

Year:

Session type:

Theme:

Liye Chen1,Wei Zhang2,Russell Leek1,Francesca Buffa1,Emmanouill Fokas1,Adrian Harris1,Shijie Cai1

1Department of Oncology, University of Oxford, Oxford, UK,2Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK


Residual oropharyngeal cancer following radical radiotherapy

Year:

Session type:

Theme:

Kirsty MacLennan1,Aravindhan Sundaramurthy1,Ioanna Fragkandrea-Nixon1

1Edinburgh Cancer Centre, Edinburgh, UK